ZNTL - Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit | Benzinga
NEW YORK and SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that members of the management team will participate in a virtual fireside chat during the TD Cowen 5th Annual Oncology Innovation Summit: Insights for ASCO and EHA on May 28, 2024 at 10:30 a.m. ET.
Access to a live webcast of this event, as well as an archived recording, will be available under the "Events & Presentations" tab on the Investors & Media section of the Company's ...